Neo-Adjuvant Immunotherapy With Nivolumab for Non Small Cell Lung Cancer Patients
Clinical trial NCT03081689 · COMPLETED
Trial details
- NCT number
- NCT03081689
- Sponsor
- Spanish Lung Cancer Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-15
- Primary completion
- 2023-09-15
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.